Donaldson, C, Hundley, V. and McIntosh, E, 1996. Using economics alongside clinical trials: why we cannot choose the evaluation technique in advance. Health economics, 5 (3), pp. 267-269.
Full text not available from this repository.
When drafting protocols for the use of economic evaluation alongside clinical trials, it is common to have to specify which type of economic evaluation is going to be carried out. Will it be a cost-benefit analysis (CBA), cost-effectiveness analysis (CEA) or a cost-utility analysis (CUA)? It is our contention that prior specification of the appropriate economic technique is not possible, in the majority of cases, until data on effectiveness and cost are actually available. In this letter, we aim to demonstrate the thinking behind our contention and to illustrate this with two case studies; one of a recent randomised trial, the other of a trial currently in progress.
|Subjects:||Technology > Medicine and Health > Nursing and Midwifery|
|Group:||School of Health and Social Care > Centre for Midwifery, Maternal and Perinatal Health|
|Deposited By:||Professor Vanora Hundley|
|Deposited On:||15 Mar 2012 12:28|
|Last Modified:||07 Mar 2013 15:54|
|Repository Staff Only -|
|BU Staff Only -|
|Help Guide -||Editing Your Items in BURO|